Nikhil Prasad Fact checked by:Thailand Medical News Team Jun 03, 2026 1 hour, 7 minutes ago
Medical News: For decades, diclofenac has been one of the most widely used medications for treating pain and inflammation. However, long-term use of the drug can cause unwanted side effects involving the stomach, kidneys, and cardiovascular system. Now, scientists from Mexico have discovered that an extract derived from the blue agave plant—the same plant used to make tequila—may significantly enhance the pain-relieving effects of diclofenac while potentially allowing lower doses of the drug to be used.
Blue agave extract shows powerful synergy with diclofenac, raising hopes for safer inflammatory pain treatments
The research was conducted by scientists from the Universidad de Guanajuato, Universidad Autónoma de Chiapas, and the Division of Life Sciences at the Universidad de Guanajuato in Mexico. Their findings suggest that compounds found in Agave tequilana could become valuable partners in future pain-management therapies.
Searching for Safer Pain Treatments
Inflammatory pain affects millions of people worldwide and is often associated with injuries, arthritis, and various chronic diseases. While nonsteroidal anti-inflammatory drugs (NSAIDs) such as diclofenac are highly effective, prolonged use can increase the risk of gastrointestinal bleeding, kidney damage, and cardiovascular complications.
Because of these concerns, researchers have been exploring natural products that could work alongside existing medications. Agave tequilana, commonly known as blue agave, has attracted growing scientific interest due to its rich mixture of biologically active compounds, including fructans, fatty acids, sterols, and saponins that may possess anti-inflammatory properties.
What the Researchers Found
The scientists tested a dry juice extract of Agave tequilana, known as ESPA, in laboratory mice experiencing inflammatory pain. The extract was compared with diclofenac and also tested in combination with the drug.
Results showed that the agave extract alone significantly reduced inflammatory pain responses. While diclofenac remained the more powerful painkiller, the agave extract consistently reduced pain-related behaviors during the inflammatory phase of the experiment.
One of the most important findings emerged when researchers combined the agave extract with diclofenac. The combination produced a much stronger effect than expected. In fact, the mixture achieved similar pain-relieving benefits while using substantially lower doses than would normally be required if each treatment were used separately.
This type of interaction is known as pharmacological synergy, meaning the two substances enhance each other's effectiveness.
Key Compounds Hidden Inside Blue Agave
Chemical analysis revealed that the extract contained several potentially beneficial compounds. Among the most abundant were palmitic acid, stearic acid, and oleic acid—naturally occurring fatty acids that have previously been linked to anti-inflammatory activity.
The researchers found that palmitic acid represented more
than 22 percent of the detectable fatty-acid profile, while stearic acid and oleic acid also appeared in significant amounts. Computer modeling suggested these compounds may influence biological pathways involved in inflammation, including those related to prostaglandins, leukotrienes, and inflammatory cytokines.
The team also discovered that some of these compounds may interact with cyclooxygenase enzymes, commonly known as COX-1 and COX-2, which are the same targets affected by diclofenac and many other NSAID drugs.
Safety Findings Offer Encouragement
Another encouraging result was the safety profile of the agave extract. Mice given extremely high doses of the extract showed no signs of toxicity, no major behavioral changes, and no evidence of damage to major organs.
The findings suggest that the extract possesses a relatively favorable short-term safety profile, although researchers emphasized that longer-term safety studies are still needed before any human applications can be considered.
In the middle of the investigation, this
Medical News report notes that the researchers stressed that the extract should not be viewed as a single active ingredient. Instead, it is a complex mixture containing numerous compounds that may work together to produce the observed effects.
Why the Discovery Matters
The most exciting aspect of the study is not simply that blue agave showed pain-relieving activity. Rather, it demonstrated an ability to amplify the effectiveness of diclofenac. This could eventually lead to treatment strategies that require lower NSAID doses, reducing the risk of side effects while maintaining pain control.
Researchers caution that the findings are still preliminary and were obtained in animal models. Additional studies are needed to identify the exact active compounds, confirm the biological mechanisms involved, and determine whether similar benefits occur in humans.
Conclusion
The study provides compelling new evidence that a dry extract from Agave tequilana possesses meaningful anti-inflammatory and pain-relieving properties. More importantly, when combined with diclofenac, the extract produced a remarkable synergistic effect that significantly enhanced pain control while potentially allowing lower drug doses to be used. The findings open the door to the development of future combination therapies that blend natural plant-derived compounds with conventional medicines. Although much work remains before clinical use becomes possible, the research highlights the growing potential of blue agave as a valuable contributor to safer and more effective pain-management strategies in the future.
The study findings were published in the peer reviewed journal: Pharmaceuticals.
https://www.mdpi.com/1424-8247/19/6/863
For the latest pharmaceutical research, keep on logging to Thailand
Medical News.
Read Also:
https://www.thailandmedical.news/articles/med-news
https://www.thailandmedical.news/articles/pharma-news
Share
Tweet
Share
